Bensler LLC Invests $1.32 Million in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bensler LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 2,522 shares of the medical equipment provider's stock, valued at approximately $1,316,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Berbice Capital Management LLC purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth $26,000. Godsey & Gibb Inc. boosted its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical in the third quarter valued at approximately $38,000. Institutional investors own 83.64% of the company's stock.

Insider Buying and Selling

In other news, CEO Gary S. Guthart sold 18,151 shares of the business's stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares of the company's stock, valued at $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 270 shares of the business's stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the sale, the chief financial officer now owns 8,757 shares of the company's stock, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 42,265 shares of company stock worth $21,964,281 in the last quarter. Corporate insiders own 0.90% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently commented on ISRG. Jefferies Financial Group increased their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday. Wells Fargo & Company lifted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a research note on Friday. Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and raised their price objective for the company from $522.00 to $650.00 in a report on Monday, December 2nd. Stifel Nicolaus upped their target price on Intuitive Surgical from $525.00 to $610.00 and gave the stock a "buy" rating in a research note on Thursday, December 5th. Finally, Leerink Partners lifted their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.

Intuitive Surgical Trading Up 0.1 %

NASDAQ:ISRG traded up $0.66 during trading hours on Tuesday, reaching $574.14. 2,331,432 shares of the company traded hands, compared to its average volume of 2,043,553. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market capitalization of $204.50 billion, a P/E ratio of 92.31, a P/E/G ratio of 5.19 and a beta of 1.39. The business's 50-day moving average price is $548.00 and its two-hundred day moving average price is $506.12.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.